Single-cell Multiomics Reveals Endothelial Mechanosensitive PIEZO1 Coupling IL-33 Regulates the Development of Pulmonary Fibrosis

Shanze Chen,Lanlan Zhang,xin zhang,Xuezhen Gui,Shu Xia,Yingyun Fu,Qian-Fang Meng,Qun Luo,Xing Shi,Bingxin Guo,Ruifang Liang,Ludan Yue,Xue Chen,Haizhao Xu,Pengbo Wang,Xia Tong,Lujie Liu,Lingwei Wang,Baicun Li,Zi Chen,Linfu Zhou,Lang Rao,Bi-Sen Ding,Rongchang Chen
DOI: https://doi.org/10.21203/rs.3.rs-4861689/v1
2024-01-01
Abstract:Pulmonary fibrosis (PF) is a lethal lung disease characterized by aberrant lung scarring. Vascular endothelial cells (VECs), which activate fibroblasts through secreting pro-fibrotic molecules, are vital for the PF development. However, the regulatory mechanisms are not fully understood. Here, by employing single-cell multiomics to analyze samples from PF patients and bleomycin (BLM) and SiO2-induced PF mouse models, we discovered that increased mechanical force and mechanosensitive PIEZO1 on VECs are closely associated with PF development, Subsequently, EC-specific deletion of PIEZO1 significantly reduced BLM-induced mouse PF, thereby further validated the critical role of endothelial PIEZO1 in PF. Mechanistically, PIEZO1 activation couples with a pro-fibrotic molecule interleukin-33 (IL-33) to drive the PF development via calpain-2 (CAPN2)-signal transducer and activator of transcription 3 (STAT3) axis. Additionally, PIEZO1 antagonist GsMTx4 effectively alleviated fibrotic outcome, while agonist YODA1 exacerbated the results in mouse model. Our findings reveals the therapeutic potential of mechanosensitive pathways for PF.
What problem does this paper attempt to address?